Premium
CAMTA1 T polymorphism is associated with neuropsychological test performance in older adults with cardiovascular disease
Author(s) -
MILLER Lindsay A.,
GUNSTAD John,
SPITZNAGEL Mary Beth,
MCCAFFERY Jeanne,
MCGEARY John,
POPPAS Athena,
PAUL Robert H.,
SWEET Lawrence H.,
COHEN Ronald A.
Publication year - 2011
Publication title -
psychogeriatrics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.647
H-Index - 32
eISSN - 1479-8301
pISSN - 1346-3500
DOI - 10.1111/j.1479-8301.2011.00357.x
Subject(s) - allele , disease , neurocognitive , dementia , medicine , neuropsychology , genotype , cognition , psychomotor learning , psychology , psychiatry , genetics , biology , gene
Background: Cardiovascular disease has long been associated with poor neurocognitive outcome, with multiple pathophysiological mechanisms that are linked to cognitive impairment in older adults. Although less frequently examined, insulin dysregulation is known to affect vascular function and the associated brain dysfunction in cardiovascular disease. Accordingly, genetic factors tied to insulin regulation may make certain people with cardiovascular disease more susceptible to cognitive dysfunction. Specifically, the calmodulin‐binding transcription activator 1 ( CAMTA1 ) genotype, which has been examined as a risk factor for Type 2 diabetes and has been linked to reduced episodic memory performance in healthy young adults, is a potential candidate gene. Methods: Blood samples were obtained from 113 older adults with cardiovascular disease who also underwent neuropsychological testing. Carriers of either one or two copies of the T allele of CAMTA1 were categorized into one group ( n = 63), whereas non‐carriers were categorized into a second group ( n = 50). Results: Analyses showed that carriers of the T allele performed more poorly on tests of attention, executive function, and psychomotor speed, but not on tests of memory. Carriers of the T allele also performed more poorly on a measure of global cognitive function. Conclusions: Results indicate that CAMTA1 genotype is associated with cognitive function in older adults with cardiovascular disease, because carriers of the T allele performed more poorly on tests of attention, executive function, and psychomotor speed. Contrary to expectations, there were no differences in memory performance among carriers and non‐carriers of the T allele. Given these mixed findings, further studies are necessary to elucidate the association between CAMTA1 and cognition, particularly gene expression and neuroimaging studies.